Torrent Pharmaceuticals (TORNTPHARM) — Financial Results

Torrent Pharmaceuticals reported a 69.9% YoY revenue increase to ₹87.22 crores for Q1 FY25, driven by strong domestic growth, while net profit rose 32% to ₹32.15 crores on higher sales and margin expansion.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"How does this financial results affect Torrent Pharmaceuticals Limited's outlook?" "What did Torrent Pharmaceuticals Limited announce on 31 July 2025?" "Is this positive or negative for TORNTPHARM?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 31 July 2025

SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results RELIANCE Reliance Industries Limited Corporate Action SBICARD SBI Cards and Payment Services Limited Annual Report SRF SRF Limited Financial Results SBILIFE SBI Life Insurance Company Limited Financial Results TATASTEEL Tata Steel Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.